Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo

Journal of Psychopharmacology

Volumn 26, Issue 6, 2012, Pages 778-783

  Davidson, Jonathan ^a   Stein, Dan J ^b   Rothbaum, Barbara O ^c   Pedersen, Ron ^d   Szumski, Annette ^d   Baldwin, David S ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PFIZER INC   (United States)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Posttraumatic stress disorder; remission; resilience; venlafaxine extended release

Indexed keywords

PLACEBO; VENLAFAXINE;

ADULT; CLINICIAN ADMINISTERED POSTTRAUMATIC STRESS DISORDER SCALE; CONNOR DAVIDSON RESILIENCE SCALE; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE SEVERITY; DRUG EFFICACY; DRUG RELEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; TREATMENT RESPONSE;

CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RESILIENCE, PSYCHOLOGICAL; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 84862133695     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111413821     Document Type: Review

References (30)

1. Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JRT, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005 ; 19: 567-596
2. Benight CC, Antoni MH, Kilbourn K, Ironson G, Kumar MA, Fletcher MA, et al. Coping self-efficacy buffers psychological and physiological disturbances in HIV-infected men following a natural disaster. Health Psychol. 1997 ; 16: 248-255
3. Benight CC, Bandura A. Social cognitive theory of posttraumatic recovery: The role of perceived self-efficacy. Behav Res Ther. 2004 ; 42: 1129-1148
4. Benight CC, Harper ML. Coping self-efficacy perceptions as a mediator between acute stress response and long-term distress following natural disasters. J Trauma Stress. 2002 ; 15: 177-186
5. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995 ; 8: 75-90
6. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P. Trauma and posttraumatic stress disorder in the community: The 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry. 1998 ; 55: 626-632
7. Camardese G, Adamo F, Mosca L, Picello A, Pizi G, Mattioli B, et al. Plasma cortisol levels and resilience in depressed patients. Eur Neuropsychopharmacol. 2007 ; 17: S338 - S339
8. Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-Davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilience. J Trauma Stress. 2007 ; 20: 1019-1028
9. Charney DS. Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress. Am J Psychiatry. 2004 ; 161: 195-216
10. Connor KM, Davidson JR. Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003 ; 18: 76-82
11. Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: A 6-month randomized, controlled trial. Arch Gen Psychiatry. 2006a ; 63: 1158-1165
12. Davidson J, Baldwin DS, Stein DJ, Pedersen R, Ahmed S, Musgnung J, et al. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: An item analysis of the Connor-Davidson Resilience Scale. Int Clin Psychopharmacol. 2008 ; 23: 299-303
13. Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ. Venlafaxine extended release in posttraumatic stress disorder: A sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006b ; 26: 259-267
14. Davidson JR, Payne VM, Connor KM, Foa EB, Rothbaum BO, Hertzberg MA, et al. Trauma, resilience and saliostasis: Effects of treatment in post-traumatic stress disorder. Int Clin Psychopharmacol. 2005 ; 20: 43-48
15. Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med. 2003 ; 65: 564-570
16. Fava GA, Rafanelli C, Cazzaro M, Conti S, Grandi S. Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med. 1998 ; 28: 475-480
17. Fava GA, Ruini C, Rafanelli C, Finos L, Salmaso L, Mangelli L, et al. Well-being therapy of generalized anxiety disorder. Psychother Psychosom. 2005 ; 74: 26-30
18. Heinrichs M, Wagner D, Schoch W, Soravia LM, Hellhammer DH, Ehlert U. Predicting posttraumatic stress symptoms from pretraumatic risk factors: A 2-year prospective follow-up study in firefighters. Am J Psychiatry. 2005 ; 162: 2276-2286
19. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in US Soldiers returning from Iraq. N Engl J Med. 2008 ; 358: 453-463
20. Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 ; 62: 593-602
21. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995 ; 52: 1048-1060
22. Lavretsky H, Siddarth P, Irwin MR. Improving depression and enhancing resilience in family dementia caregivers: A pilot randomized placebo-controlled trial of escitalopram. Am J Geriatr Psychiatry. 2010 ; 18: 154-162
23. Lenox RH, Gould TD, Manji HK. Endophenotypes in bipolar disorder. Am J Med Genet. 2002 ; 114: 391-406
24. Morgan CA III, Wang S, Southwick SM, Rasmusson A, Hazlett G, Hauger RL, et al. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry. 2000 ; 47: 902-909
25. Pagano ME, Friend KB, Tonigan JS, Stout RL. Helping other alcoholics in alcoholics anonymous and drinking outcomes: Findings from project MATCH. J Stud Alcohol. 2004 ; 65: 766-773
26. Roy A, Sarchiapone M, Carli V. Low resilience in suicide attempters. Arch Suicide Res. 2007 ; 11: 265-269
27. Saigh PA, Mroueh M, Zimmerman BJ, Fairbank JA. Self-efficacy expectations among traumatized adolescents. Behav Res Ther. 1995 ; 33: 701-704
28. Vaishnavi S, Connor K, Davidson JR. An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: Psychometric properties and applications in psychopharmacological trials. Psychiatry Res. 2007 ; 152: 293-297
29. Effexor XR. Philadelphia,PA: ; 2006 :
30. Yehuda R. Risk and resilience in posttraumatic stress disorder. J Clin Psychiatry. 2004 ; 65: 29-36